Lazard Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $649M | Buy |
|
|||||
|
2025
Q1 | $775M | Buy |
|
|||||
|
2024
Q4 | $776M | Sell |
|
|||||
|
2024
Q3 | $1.11B | Sell |
|
|||||
|
2024
Q2 | $999M | Sell |
|
|||||
|
2024
Q1 | $1.07B | Sell |
|
|||||
|
2023
Q4 | $997M | Sell |
|
|||||
|
2023
Q3 | $968M | Sell |
|
|||||
|
2023
Q2 | $1.02B | Buy |
|
|||||
|
2023
Q1 | $1.11B | Buy |
|
|||||
|
2022
Q4 | $1.03B | Sell |
|
|||||
|
2022
Q3 | $953M | Sell |
|
|||||
|
2022
Q2 | $1.04B | Sell |
|
|||||
|
2022
Q1 | $1.16B | Sell |
|
|||||
|
2021
Q4 | $1.37B | Sell |
|
|||||
|
2021
Q3 | $1.19B | Sell |
|
|||||
|
2021
Q2 | $1.07B | Buy |
|
|||||
|
2021
Q1 | $898M | Sell |
|
|||||
|
2020
Q4 | $922M | Buy |
|
|||||
|
2020
Q3 | $866M | Sell |
|
|||||
|
2020
Q2 | $755M | Buy |
|
|||||
|
2020
Q1 | $506M | Sell |
|
|||||
|
2019
Q4 | $580M | Buy |
|
|||||
|
2019
Q3 | $506M | Sell |
|
|||||
|
2019
Q2 | $565M | Sell |
|
|||||
|
2019
Q1 | $622M | Buy |
|
|||||
|
2018
Q4 | $492M | Buy |
|
|||||
|
2018
Q3 | $467M | Buy |
|
|||||
|
2018
Q2 | $302M | Buy |
|
|||||
|
2018
Q1 | $297M | Buy |
|
|||||
|
2017
Q4 | $249M | Buy |
|
|||||
|
2017
Q3 | $219M | Buy |
|
|||||
|
2017
Q2 | $201M | Buy |
|
|||||
|
2017
Q1 | $167M | Sell |
|
|||||
|
2016
Q4 | $154M | Sell |
|
|||||
|
2016
Q3 | $228M | Sell |
|
|||||
|
2016
Q2 | $224M | Sell |
|
|||||
|
2016
Q1 | $253M | Buy |
|
|||||
|
2015
Q4 | $213M | Buy |
|
|||||
|
2015
Q3 | $129M | Buy |
|
|||||
|
2015
Q2 | $94.8M | Buy |
|
|||||
|
2015
Q1 | $67.3M | Sell |
|
|||||
|
2014
Q4 | $72.9M | Buy |
|
|||||
|
2014
Q3 | $52.2M | Buy |
|
|||||
|
2014
Q2 | $44.4M | Buy |
|
|||||
|
2014
Q1 | $43.6M | Buy |
|
|||||
|
2013
Q4 | $1.39M | Hold |
|
|||||
|
2013
Q3 | $1.15M | Sell |
|
|||||
|
2013
Q2 | $1.1M | Buy |
|